PEOPLE living with glaucoma in Falkirk will soon be able to access support at a local optician - rather than travel to a ...

Q1 2024 Earnings Call Transcript May 5, 2024 Sight Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds ...

Swiss-American ophthalmology company Alcon (SWX: ALC) is acquiring Israeli glaucoma treatment company Belkin Vision for up to ...

Jefferies expects healthy iDose uptake to support sales growth acceleration in 25E/26E, along with stability in the base ...

Travoprost Ophthalmic Solution USP, 0.004% (RLD Travatan Z), had estimated annual sales of USD 77 million in the U.S. (IQVIA MAT March 2024).

Controversies in Modern Eye Care conference, held on May 4, 2024, in Los Angeles, was co-chaired by Neda Shamie, MD, and ...

Have you heard about an eye condition that can lead to irreversible vision loss if not treated on time? Glaucoma is a group ...

DeMontis, now 37, began directing the challenge of his diminished sight into powerful words and trailblazing deed. His energy ...

MIAMI, FL — Fifteen Bascom Palmer Eye Institute physicians were selected for the 2024 Power List, a selection of the world’s ...

The anticipated near-term sales growth inflection for iDose, combined with the sustained performance of Glaukos’s core glaucoma and corneal health franchises, underpins the upgrade to a Buy rating.

Glaucoma UK was accepting applications from clinical and non-clinical researchers for the Open Call Research Award 2024, ...

Rick Lewis, chief medical officer of ViaLase, describes the company's nonincisional glaucoma treatment, showing promising ...